Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Ultra Care Inc (UCLA.OB) since 2008 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data at Ultra Care Inc. Table 2 shows the detailed insider transactions. The reporting company's CIK number is 1415605.
Total stock buying since 2008: $0.
Total stock sales since 2008: $72,000,012,000.
Total stock option exercises since 2008: $0.
▪ Recent SEC 13D filings for UCLA.OB
▪ Recent SEC 13D filings for all companies
▪ Recent portfolio reports of all companies
A schedule 13D must be filed with the SEC when a person or group of persons acquires beneficial ownership of more than 5% of Ultra Care Inc (UCLA.OB). A schedule 13D/A is an amendment that is filed when there are any material changes in beneficial ownership.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2009 | 0 | $0 | 1,200,000 | $72,000,000,000 | 0 | $0 |
| 2008 | 0 | $0 | 1,200,000 | $12,000 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2009-01 | 0 | $0 | 1,200,000 | $72,000,000,000 | 0 | $0 |
| 2008-09 | 0 | $0 | 1,200,000 | $12,000 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2009-01-15 | Pagaduan Van Clayton Agayo (Other) | Sale | 1,200,000 | 60,000.00 | 72,000,000,000 |
| 2008-09-15 | Melchor Denver (Other) | Sale | 700,000 | .01 | 7,000 |
| 2008-09-15 | Belgica Clifford (Other) | Sale | 500,000 | .01 | 5,000 |
Insider trading activities including stock purchases, stock sales, and option exercises of UCLA.OB listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Ultra Care Inc (symbol UCLA.OB, CIK number 1415605) see the Securities and Exchange Commission (SEC) website.